default author photo

Jussi Pihlajamäki

University of Eastern Finland - Department of Clinical Nutrition

Kuopio

Finland

SCHOLARLY PAPERS

2

DOWNLOADS

113

TOTAL CITATIONS

2

Scholarly Papers (2)

1.

PCSK9 rs11591147 R46L Loss-of-Function Variant Protects Against Liver Damage in Individuals with NAFLD

Number of pages: 34 Posted: 19 May 2020
- Section of Gastroenterology and Hepatology, AstraZeneca Pharmaceuticals - Bioscience Metabolism, Research and Early Development Cardiovascular, Renal and Metabolism (CVRM), Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Parma - Dipartimento di Economia, University of Gothenburg - Department of Molecular and Clinical Medicine, University of Eastern Finland - Department of Clinical Nutrition, AstraZeneca Pharmaceuticals - Bioscience Metabolism, Research and Early Development Cardiovascular, Renal and Metabolism (CVRM), AstraZeneca Pharmaceuticals - Bioscience Cardiovascular, Research and Early Development Cardiovascular, Renal and Metabolism, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico - General Medicine and Metabolic Diseases, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Florence - Department of Experimental and Clinical Medicine, University of Eastern Finland - Department of Medicine, affiliation not provided to SSRN, AstraZeneca Pharmaceuticals - IMED Biotech Unit, - Section of Gastroenterology and Hepatology, - Biomedical Department of Internal and Specialized Medicine (DI.BI.M.I.S.), Magna Graecia University of Catanzaro - Department of Experimental and Clinical Medicine, - Section of Gastroenterology and Hepatology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico - General Medicine and Metabolic Diseases, University of Milan - Department of Pathophysiology and Transplantation, University of Gothenburg - Department of Molecular and Clinical Medicine and - Section of Gastroenterology and Hepatology
Downloads 83 (783,685)

Abstract:

Loading...

NASH, NAFLD, FIBROSIS, PCSK9

2.

NR1H4 rs35724 G>C Variant Modulates Liver Damage in Nonalcoholic Fatty Liver Disease

Number of pages: 26 Posted: 14 Dec 2020
- Section of Gastroenterology and Hepatology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico - General Medicine and Metabolic Diseases, University of Eastern Finland - Department of Clinical Nutrition, University of Sydney - Storr Liver Centre, University of Helsinki - Department of Medicine, - Section of Gastroenterology and Hepatology, University of Milan - Department of Pathophysiology and Transplantation, - Section of Gastroenterology and Hepatology, - Section of Gastroenterology and Hepatology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico - General Medicine and Metabolic Diseases, - Section of Gastroenterology and Hepatology, Fondazione IRCCS Cà Granda Pad Marangoni - Translational Medicine, - Section of Gastroenterology and Hepatology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico - Department of Pathophysiology and Transplantation, - Section of Gastroenterology and Hepatology, University of Sydney - Storr Liver Centre, University of Gothenburg - Department of Molecular and Clinical Medicine, University of Milan - Department of Pathophysiology and Transplantation and - Section of Gastroenterology and Hepatology
Downloads 30 (1,318,317)
Citation 2

Abstract:

Loading...